Arbaclofen

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameArbaclofen
Drug Alias NameArbaclofenum阿巴氯芬ArbaclofenoSTX-209AGI-006 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-Aminobutyric Acid B Receptor agonists
TargetsGamma-Aminobutyric Acid B Receptor
Therapy Area/IndicationsAutistic DisorderAutism Spectrum DisorderFragile X Syndrome +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBosnia and HerzegovinaBulgariaCanada +[11] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesHorizon Therapeutics PLC
China Registration ClassN/A

Develop Information

Active CompaniesRvl Pharmaceuticals IncAllos Pharma IncUniversity of Toronto +[6] 
Inactive CompaniesSeaside Therapeutics Inc
Active IndicationsAutism Spectrum DisorderMuscle Spasticity
Inactive IndicationsAutistic DisorderFragile X SyndromeMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG